Attached below are the directions. I can send the required information so that you can quickly finish up the work.

Please read Case study 5.2 and answer the questions at the end about the caseDISCUSSION QUESTIONS1. What explains the high price of prescription medicines in the United States? What if anything should be done about it? Do you believe that in the United States drug prices reflect the operation of a fair and competitive market?2. Given the nature of their product, do pharmaceutical companies have ethical responsibilities that other corporations don’t have? In your view, are the large U.S. drug companies good corporate citizens?3. Are the large drug companies guilty of price gouging or of charging an unfair or exploitative price for their products? Should Americans be permitted to import drugs from Canada or other countries?4. Assess the motivations of drug companies that do their testing overseas. Do you think test subjects are being exploited or taken advantage of? Under what circumstances, if any, are companies morally justified in testing overseas?5. Do drug companies have an obligation to make new drugs available to patients who were involved in their development, either here or overseas? Does the size of the company make a difference? What would you do if you were Dr. Lange? What obligations, ideals, and consequences should he take into account?6. Is it ethical for companies to decline to sell a useful drug like ranolazine in a poor country because they can make more money marketing it elsewhere?7. When it comes to life-saving drugs, do pharmaceuti-cal companies have a moral obligation to make them available in poor countries at little or no cost? Explain why or why not. What about effective but non-life-saving drugs like ranolazine?

I have attached the below in a Word DOX. as formatting can be lost. I have also attached the MOD8 Portfolio Project in a Word DOX. for your reference.    Portfolio Milestone (100 Points) Important! Read First Choose one of the following two assignments to complete this week. Do  not do both assignments. Identify your assignment choice in the title  of your submission. Option #1: Quality Management and Small Cell Infrastructure Design  Go to Module 8 and read the expectations for Option 1, then return here for your Module 3 Milestone effort. In Module 3, you are asked as a first step, to familiarize yourself  with the Small Cell Infrastructure Design Guidelines. Note that two  contract firms were instrumental in the development of the guidelines:  Clanton & Associates, Inc. and Jacobs Engineering Group. After your  review of the guidelines, you are asked to provide your input to the  following: Are the current Small Cell Infrastructure Design Guidelines (SCIDG)  ones that promote high quality? If yes, how? If no, why not and what  should change to promote quality? Support your position with specific  references to the SCIDG or current scholarly documentation. What do you interpret to be meant by “quality” from the perspective  of the public works personnel, communications companies deploying small  cell infrastructure, the contract companies involved, and the public  both now and in the future? What support do you have for your position  with specific references to the SCIDG or current scholarly  documentation? What are the drivers for change, and the barriers to change from the  perspective of the public works personnel and the public? Are there  competing drivers for change that may impact quality from the public’s  perspective? Support your position with specific references to the SCIDG  or current scholarly documentation. Submission: Write a paper addressing the Module 3 Milestone questions for the  case of The Department of Public Works, Engineering Division for the  City and County of regarding the Small Cell Infrastructure Design  Guidelines and quality management. Your paper should be 3-4 pages in  length, not including the required title and references pages and any  appendix if required. For more information see “How do I do an Appendix in APA style?” (Links to an external site.)  Support the Milestone paper with a minimum of three current  (published in the most recent five years) scholarly sources from the  CSU-Global Library. This is in addition to any course textbooks, lecture  material you decide to use, or the case itself. Of course, you may  always exceed the minimum number of sources. Format the paper according to the CSU-Global Guide to Writing & APA (Links to an external site.). Be clear, concise, and focused. Option #2: Total quality management and the Office of Personnel Management (OPM) on Federal Retirements  Go to Module 8 and read the expectations for Option 2, then return here for your Module 3 Milestone effort. In Module 3, you are asked as a first step, to familiarize yourself  with the Government Accounting Office (GAO), Office of Personnel  Management (OPM) May of 2019, publication of the Federal Retirement: OPM  Actions Needed to Improve Application Processing Times. After your  review of the guidelines, you are asked to provide your input to the  following: Is the current Federal Retirement: OPM Actions Needed to Improve  Application Processing Times document one that promotes high quality? If  yes, how? If no, why not and what should change to promote quality?  Support your position with specific references to the GAO report or  current scholarly documentation. What do you interpret to be meant by “quality” from the perspective  of the GAO OPM, retirees, Congressional leaders, and the public both now  and in the future? What support do you have for your position with  specific references to the GAO report or current scholarly  documentation? What are the drivers for change, and the barriers to change from the  perspective of the GAO OPM, retirees, Congressional leaders, and the  public? Are there competing drivers for change that may impact quality  from the public’s perspective? Support your position with specific  references to the GAO report or current scholarly documentation.